Studies indicate that one-third of cancer patients take combinations of medications (both prescribed and non-prescription/over-the-counter drugs) that place them at risk of potentially dangerous interactions. (Read More Here) This number may ... [Read More]
In this section, you will learn about various conventional cancer therapies, pharmaceutical drugs, procedures and tests that are either innovative or merely interesting topics that Dr. Lawenda wants to share with patients.
In a study published, in June 2010 (in the Journal of Clinical Oncology) investigators have found that over 50% of breast cancer patients, who have been prescribed hormonal therapy medications ("aromatase inhibitors" or "Tamoxifen") for preventing ... [Read More]
In a study published in late June/early July 2010 (in the journal Cancer) investigators report that men who underwent surgery for prostate cancer and had been taking a common cholesterol lowering medication ("statins"), at the time of surgery, were ... [Read More]
In two large studies, published in June 2010 (in the Journal of Clinical Oncology) investigators report that the use of a class of osteoporosis medications called, "bisphosphonates" significantly reduced the risk of developing invasive breast cancer ... [Read More]
Increasingly, we are learning that adults with diabetes (particularly, type 2 diabetes or non-insulin dependent diabetes- "NIDDM") have an increased risk of developing a variety of cancers. Researchers have suggested numerous possible hypotheses to ... [Read More]
In a study (accepted for publication in May 2006, in Menopause: The Journal of The North American Menopause Society) investigators found the the use of progesterone increased the risk of breast cancer metastases. The authors conducted this study in ... [Read More]
The FDA approved a new prostate cancer vaccine (Provenge) in April 2010. This vaccine stimulates the body's immune system by helping specific cancer-fighting cells (dendritic cells) to identify and destroy prostate cancer cells. The therapy requires ... [Read More]